Company to report third quarter 2026 financial results and host conference call at 8:30 a.m. ET HOUSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) — Cerenome, Inc. (Nasdaq: CNSY) (“Cerenome” or the “Company”), a CNS oncology company integrating diagnostics, therapeutics, and artificial intelligence, today…